Is there a role for adjuvant therapy in resected adenocarcinoma of the small intestine

Acta Oncologica

Volumn 49, Issue 4, 2010, Pages 474-479

  Overman, Michael J ^a   Kopetz, Scott ^a   Lin, E ^a   Abbruzzese, James L ^a   Wolff, Robert A ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CAPECITABINE; CISPLATIN; FLUOROURACIL; IRINOTECAN; OXALIPLATIN;

ADJUVANT THERAPY; ADULT; AGED; ARTICLE; CANCER ADJUVANT THERAPY; CANCER CHEMOTHERAPY; CANCER LOCALIZATION; CANCER RADIOTHERAPY; CANCER RELAPSE; CANCER RISK; CANCER STAGING; CANCER SURGERY; CANCER SURVIVAL; CONTROLLED STUDY; DISEASE FREE SURVIVAL; DUODENUM; FEMALE; HUMAN; ILEUM; JEJUNUM; LYMPH NODE; MAJOR CLINICAL STUDY; MALE; OVERALL SURVIVAL; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SMALL INTESTINE ADENOCARCINOMA; SMALL INTESTINE CANCER; TREATMENT OUTCOME;

ADENOCARCINOMA; ADULT; AGED; ANALYSIS OF VARIANCE; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CHEMOTHERAPY, ADJUVANT; DISEASE-FREE SURVIVAL; DUODENAL NEOPLASMS; FEMALE; FOLLOW-UP STUDIES; HUMANS; ILEAL NEOPLASMS; INTESTINAL NEOPLASMS; INTESTINE, SMALL; JEJUNAL NEOPLASMS; KAPLAN-MEIERS ESTIMATE; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; NEOPLASM STAGING; PROPORTIONAL HAZARDS MODELS; RADIOTHERAPY, ADJUVANT; RETROSPECTIVE STUDIES; TREATMENT OUTCOME;

EID: 77951238173     PISSN: 0284186X     EISSN: 1651226X     Source Type: Journal    
DOI: 10.3109/02841860903490051     Document Type: Article

References (24)

1. Bilimoria KY, Bentrem DJ, Wayne JD, Ko CY, Bennett CL, Talamonti MS. Small bowel cancer in the United States: Changes in epidemiology, treatment, and survival over the last 20 years. Ann Surg 2009;249:63-71.
2. Jemal A, Siegel R, Ward E, et al. Cancer statistics, 2008. CA Cancer J Clin 2008;58:71-96.
3. Howe JR, Karnell LH, Menck HR, Scott-Conner C. The American College of Surgeons Commission on Cancer and the American Cancer Society. Adenocarcinoma of the small bowel: Review of the National Cancer Data Base, 1985- 1995. Cancer 1999;86:2693-2706
4. Agrawal S, McCarron EC, Gibbs JF, Nava HR, Wilding GE, Rajput A. Surgical management and outcome in primary adenocarcinoma of the small bowel. Ann Surg Oncol 2007;14:2263-2269
5. Dabaja BS, Suki D, Pro B, Bonnen M, Ajani J. A denocarcinoma of the small bowel: Presentation, prognostic factors, and outcome of 217 patients. Cancer 2004;101:518-526
6. Ito H, Perez A, Brooks DC, et al. Surgical treatment of small bowel cancer: A 20-year single institution experience. J Gastrointest Surg 2003;7:925-930
7. Wu TJ, Yeh CN, Chao TC, Jan YY, Chen MF. Prognostic factors of primary small bowel adenocarcinoma: Univariate and multivariate analysis. World J Surg 2006;30:391-8; Discussion 399.
8. Fishman PN, Pond GR, Moore MJ, et al. Natural history and chemotherapy effectiveness for advanced adenocarcinoma of the small bowel: A retrospective review of 113 cases. Am J Clin Oncol 2006;29:225-231
9. Overman MJ, Kopetz S, Wen S, et al. Chemotherapy with 5-fl uorouracil and a platinum compound improves outcomes in metastatic small bowel adenocarcinoma. Cancer 2008;113: 2038-2045
10. Overman MJ, Varadhachary GR, Kopetz S, et al. Phase II study of capecitabine and oxaliplatin for advanced adenocarcinoma of the small bowel and ampulla of vater. J Clin Oncol 2009.
11. Bauer RL, Palmer ML, Bauer AM, Nava HR, Douglass HO, Jr. Adenocarcinoma of the small intestine: 21-year review of diagnosis, treatment, and prognosis. Ann Surg Oncol 1994;1:183-188
12. Bakaeen FG, Murr MM, Sarr MG, et al. What prognostic factors are important in duodenal adenocarcinoma? Arch Surg 2000;135:635-641
13. Barnes G, Jr., Romero L, Hess KR, Curley SA. Primary adenocarcinoma of the duodenum: Management and survival in 67 patients. Ann Surg Oncol 1994;1:73-8.
14. Swartz MJ, Hughes MA, Frassica DA, et al. Adjuvant concurrent chemoradiation for node-positive adenocarcinoma of the duodenum. Arch Surg 2007;142:285-288
15. Kelsey CR, Nelson JW, Willett CG, et al. Duodenal adenocarcinoma: Patterns of failure after resection and the role of chemoradiotherapy. Int J Radiat Oncol Biol Phys 2007;69:1436-1441
16. Andre T, Boni C, Mounedji-Boudiaf L, et al. Oxaliplatin, fl uorouracil, and leucovorin as adjuvant treatment for colon cancer. N Engl J Med 2004;350:2343-2351
17. Overman MJ, Hu C, Wolff RA, Chang GJ. Impact of lymph node evaluation on survival for small bowel adenocaricnoma: Analysis of the Surveillance, Epidemiology and End Results (SEER) database. Presented at the 2009 ASCO Annual Meeting, Orlando Florida, #4596.
18. Halfdanarson T, Quevedo, F, McWilliams, RR. Small bowel adenocarcinoma: A review of 491 cases (abstract). J Clin Oncol 2006;24:209s.
19. Klinkenbijl JH, Jeekel J, Sahmoud T, et al. Adjuvant radiotherapy and 5-fl uorouracil after curative resection of cancer of the pancreas and periampullary region: Phase III trial of the EORTC gastrointestinal tract cancer cooperative group. Ann Surg 1999;230:776-782
20. Kelsey CR. Adenocarcinoma of the duodenum: The role of radiation therapy. Paper presented at: Gastrointestinal Cancers Symposium abstract 185, 2007.
21. Abrahams NA, Halverson A, Fazio VW, Rybicki LA, Goldblum JR. Adenocarcinoma of the small bowel: A study of 37 cases with emphasis on histologic prognostic factors. Dis Colon Rectum 2002;45:1496-1502
22. Brucher BL, Stein HJ, Roder JD, et al. New aspects of prognostic factors in adenocarcinomas of the small bowel. Hepatogastroenterology 2001;48:727-732
23. Ouriel K, Adams JT. Adenocarcinoma of the small intestine. Am J Surg 1984;147:66-71.
24. Talamonti MS, Goetz LH, Rao S, Joehl RJ. Primary cancers of the small bowel: Analysis of prognostic factors and results of surgical management. Arch Surg 2002;137: 564-570